KEGG   DRUG: Delandistrogene moxeparvovec
Entry
D12633                      Drug                                   
Name
Delandistrogene moxeparvovec (USAN/INN);
Delandistrogene moxeparvovec-rokl;
Elevidys (TN)
Product
ELEVIDYS (Sarepta Therapeutics)
Remark
ATC code: M09AX15
Product: D12633<US>
Efficacy
Nervous system disease agent
  Disease
Duchenne muscular dystrophy [DS:H01963]
  Type
Gene therapy product
Comment
Recombinant adeno-associated virus AAVrh74 vector SRP-9001 MHCK7 promoter plus micro-dystrophin-specifyingTreatment of Duchenne muscular dystrophy
Target
DMD* [HSA_VAR:1756v1] [HSA:1756] [KO:K10366]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 M MUSCULO-SKELETAL SYSTEM
  M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
   M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
    M09AX Other drugs for disorders of the musculo-skeletal system
     M09AX15 Delandistrogene moxeparvovec
      D12633  Delandistrogene moxeparvovec (USAN/INN) <US>
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    DMD* [HSA_VAR:1756v1]
     D12633  Delandistrogene moxeparvovec (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D12633
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12633
Other DBs
CAS: 2305040-16-6
PubChem: 497621046
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system